These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 11748973)

  • 1. A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not?
    Carney ME; Lancaster JM; Ford C; Tsodikov A; Wiggins CL
    Gynecol Oncol; 2002 Jan; 84(1):36-42. PubMed ID: 11748973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the gynecologic oncologist on the survival of ovarian cancer patients.
    Chan JK; Kapp DS; Shin JY; Husain A; Teng NN; Berek JS; Osann K; Leiserowitz GS; Cress RD; O'Malley C
    Obstet Gynecol; 2007 Jun; 109(6):1342-50. PubMed ID: 17540806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients.
    Earle CC; Schrag D; Neville BA; Yabroff KR; Topor M; Fahey A; Trimble EL; Bodurka DC; Bristow RE; Carney M; Warren JL
    J Natl Cancer Inst; 2006 Feb; 98(3):172-80. PubMed ID: 16449677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma.
    Engelen MJ; Kos HE; Willemse PH; Aalders JG; de Vries EG; Schaapveld M; Otter R; van der Zee AG
    Cancer; 2006 Feb; 106(3):589-98. PubMed ID: 16369985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with the suboptimal treatment of women less than 55 years of age with early-stage ovarian cancer.
    Chan JK; Kapp DS; Shin JY; Osann K; Leiserowitz GS; Cress RD; O'Malley C
    Gynecol Oncol; 2008 Jan; 108(1):95-9. PubMed ID: 17949796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The benefits of a gynecologic oncologist: a pattern of care study for endometrial cancer treatment.
    Roland PY; Kelly FJ; Kulwicki CY; Blitzer P; Curcio M; Orr JW
    Gynecol Oncol; 2004 Apr; 93(1):125-30. PubMed ID: 15047225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site of oncologic specialty care for older adolescents in Utah.
    Albritton KH; Wiggins CH; Nelson HE; Weeks JC
    J Clin Oncol; 2007 Oct; 25(29):4616-21. PubMed ID: 17925557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of care in advanced ovarian cancer: the importance of provider specialty.
    Mercado C; Zingmond D; Karlan BY; Sekaris E; Gross J; Maggard-Gibbons M; Tomlinson JS; Ko CY
    Gynecol Oncol; 2010 Apr; 117(1):18-22. PubMed ID: 20106512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer: a gynecologic cancer intergroup trial of the AGO-OVAR and GINECO.
    Pfisterer J; Weber B; Reuss A; Kimmig R; du Bois A; Wagner U; Bourgeois H; Meier W; Costa S; Blohmer JU; Lortholary A; Olbricht S; Stähle A; Jackisch C; Hardy-Bessard AC; Möbus V; Quaas J; Richter B; Schröder W; Geay JF; Lück HJ; Kuhn W; Meden H; Nitz U; Pujade-Lauraine E; ;
    J Natl Cancer Inst; 2006 Aug; 98(15):1036-45. PubMed ID: 16882940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The surgical management of women with ovarian cancer in the south west of England.
    Olaitan A; Weeks J; Mocroft A; Smith J; Howe K; Murdoch J
    Br J Cancer; 2001 Dec; 85(12):1824-30. PubMed ID: 11747321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a regional network for ovarian cancer care.
    van Altena AM; van den Akker PA; de Hullu JA; Ottevanger PB; Aalders AL; Gerritse R; Happel M; Hoekstra MP; Janssen MJ; Samlal RA; Smeets KM; Snijders MP; Vasmel MJ; Vollebergh JH; Kiemeney LA; Massuger LF
    Obstet Gynecol; 2013 Sep; 122(3):668-75. PubMed ID: 23921868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Who should operate on patients with ovarian cancer? An evidence-based review.
    Giede KC; Kieser K; Dodge J; Rosen B
    Gynecol Oncol; 2005 Nov; 99(2):447-61. PubMed ID: 16126262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
    Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
    J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results.
    Tserkezoglou A; Kontou S; Hadjieleftheriou G; Apostolikas N; Vassilomanolakis M; Sikiotis K; Salamalekis E; Tseke P; Magiakos G
    Anticancer Res; 2006; 26(3B):2339-44. PubMed ID: 16821613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of women with gynecologic cancer who enter clinical trials.
    Luck MB; McIntire M; Blades N; Robinson W
    J Reprod Med; 2005 Jul; 50(7):481-5. PubMed ID: 16130843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
    Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY
    Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of ovarian cancer treatments: analysis of utility assessments of ovarian cancer patients, at-risk population, general population, and physicians.
    Calhoun EA; Fishman DA; Lurain JR; Welshman EE; Bennett CL
    Gynecol Oncol; 2004 Apr; 93(1):164-9. PubMed ID: 15047231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy.
    Juretzka MM; Barakat RR; Chi DS; Iasonos A; Dupont J; Abu-Rustum NR; Poynor EA; Aghajanian C; Spriggs D; Hensley ML; Sabbatini P
    Gynecol Oncol; 2007 Jan; 104(1):176-80. PubMed ID: 16996584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of chemotherapy use for women with ovarian cancer: a population-based study.
    Cress RD; O'Malley CD; Leiserowitz GS; Campleman SL
    J Clin Oncol; 2003 Apr; 21(8):1530-5. PubMed ID: 12697877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?
    Eisenkop SM; Spirtos NM
    Gynecol Oncol; 2001 Sep; 82(3):489-97. PubMed ID: 11520145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.